Keratoconus grafts demonstrate a high survival rate and visual outcome

Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems

Stem cells may replace some lost retinal neurons

The AI retinal scanning model will be free to use for all institutions

MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.

Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022

According to Bausch + Lomb, MIEBO (perfluorohexyloctane ophthalmic solution), commercialised as EvoTears in Europe, is the first prescription eye drop that targets tear evaporation.